Palladium-109 labeled anti-melanoma monoclonal antibodies

Patent · Mon Jan 01 00:00:00 EST 1990

OSTI ID:875259

Srivastava, Suresh C. ^[1]; Fawwaz, Rashid A. ^[2]; Ferrone, Soldano ^[3]

---

1. Setauket, NY
2. Pelham, NY
3. Scarsdale, NY

Palladium-109, a beta-emitting radionuclide, when chelated to anti-melanoma monoclonal antibody demonstrates high uptake in melanoma and thus is useful for tumor therapy.

• Research Organization: Brookhaven National Laboratory (BNL), Upton, NY (United States)
• Sponsoring Organization: USDOE
• DOE Contract Number: AC02-76CH00016
• Assignee: United States of America as represented by Secretary of Energy (Washington, DC)
• Patent Number(s): H000819
• Application Number: 06/605439
• OSTI ID: 875259
• Resource Relation: Patent File Date: 1984 Apr 30
• Country of Publication: United States
• Language: English

Related Subjects

statutory invention registration
palladium-109
labeled
anti-melanoma
monoclonal
antibodies
beta-emitting
radionuclide
chelated
antibody
demonstrates
uptake
melanoma
useful
tumor
therapy
monoclonal antibody
monoclonal antibodies
tumor therapy
emitting radionuclide
anti-melanoma monoclonal
/424/435/436/530/